Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

Abstract Background Whether a sequential or concurrent regimen of anthracyclines and taxanes is superior for breast cancer is controversial. We compared the efficacy of two regimens in patients with operable breast cancer based on all relevant published data of phase III randomized controlled trials...

Full description

Bibliographic Details
Main Authors: Wanjing Chen, Qian Tu, Yanfei Shen, Kejun Tang, Mengying Hong, Yong Shen
Format: Article
Language:English
Published: BMC 2021-02-01
Series:World Journal of Surgical Oncology
Subjects:
Breast cancer
Sequential regimen
Concurrent regimen
Anthracycline
Taxanes
Online Access:https://doi.org/10.1186/s12957-021-02150-4

Similar Items

Similar Items